Tag Archives: Biologics by McKesson

Specialty Drug, Specialty Pharmacy

Biologics by McKesson Selected to Provide TRUSELTIQ and LUMAKRAS

Posted on by John Santilli
22
Jun

Biologics specialty pharmacy teams includes pharmacists with in-depth knowledge of therapies, experienced nurses, and financial counselors who are familiar with various financial assistance programs and organizations that help patients

Continue reading →
Oncology, Specialty Pharmacy, Uncategorized

Biologics by McKesson Expands Oncology Practices Offerings

Posted on by John Santilli
23
Mar

Biologics has contracted with more than 500 payers and offers more than 150 therapies

Continue reading →
Oncology, Specialty Drug, Specialty Pharmacy

AVEO Oncology’s Limited Specialty Pharmacy Distribution Network for Fotivda Selected

Posted on by John Santilli
15
Mar

Biologics by McKesson and Onco360 continue to solidify their positions as market-leading specialty pharmacy providers of oncology drugs

Continue reading →
Specialty Pharmacy

BluePrint’s AYVAKIT and GAVRETO™ Selected Biologics and PantherRx Rare as Limited Specialty Pharmacies

Posted on by John Santilli
15
Jan

Blueprint creates medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease

Continue reading →
Oncology, Specialty Drug, Specialty Pharmacy

Biologics by McKesson and AllianceRx Expand Specialty Pharmacy Oncology Offerings

Posted on by John Santilli
31
Aug

INQOVI is for the treatment of adults with intermediate and high-risk myelodysplastic syndromes (MDS) including chronic myelomonocytic leukemia (CMML), two blood malignancies

Continue reading →
Oncology, Specialty Drug, Specialty Pharmacy

Biologics by McKesson Expands Specialty Pharmacy Oncology Offerings

Posted on by John Santilli
26
Aug

Biologics, as part of a recent reorganization, is now joining McKesson’s Provider Solutions business within the Pharmaceutical Solutions and Services (PSaS) business unit

Continue reading →
Specialty Drug, Specialty Pharmacy

Immunomedics Chooses Biologics as Sole Specialty Pharmacy Distributor

Posted on by John Santilli
18
May

Trodelvy is the first anti-Trop-2 ADC recently approved by the FDA for the treatment of adult patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease

Continue reading →
Specialty Drug, Specialty Pharmacy, Uncategorized

Limited Distribution Network for DOPTELET® Includes Biologics by McKesson

Posted on by John Santilli
23
Mar

Dova recently entered into a merger agreement with Swedish Orphan Biovitrum AB (Sobi)

Continue reading →